$XBI $90.03 | -2.1%
Covid Updates
$GILD +1.0% FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression. source
Pipeline Updates
$GNFT -1.8% GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial. source
$ARWR -3.2% Arrowhead Pharmaceuticals to Webcast Fiscal 2022 First Quarter Results. source
$PTN +0.5% Palatin Announces Presentation at the 2022 Crohn's and Colitis Congress. source
$MRTX -3.7%Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-Mutated Gastrointestinal Cancers. source
Business Updates
$ORTX -5.6% Orchard Therapeutics Announces Publication in The Lancet of Long-term Clinical Outcomes with Libmeldy for the Treatment of Children with Early-onset MLD. source
$UTHR +0.1% United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs. source
$ONCT -1.6% Oncternal Therapeutics Hosting Key Opinion Leader Webinar on Hematological Malignancies and Prostate Cancer. source
Posted by DV/FS
Comentários